Britannia Surges To Record After Q1 Revenue Beats Estimate
Bengaluru-based Britannia Industries Ltd. reported a 6.5 percent gain in sales for the April-June quarter, higher than analyst estimates.
The country's second-largest biscuit maker posted a net profit of Rs 216 crore, compared with the Rs 217 crore consensus estimate of analysts tracked by Bloomberg.
It clocked net sales of Rs 2,340 crore for the three-month period, versus Rs 2,197 crore same period a year ago, according to its stock exchange filing. Analysts had pegged revenue to come in at Rs 2,185 crore.
Earnings before interest, taxes, depreciation, and amortisation (EBITDA) rose 3.8 percent to Rs 329 crore, while operating margin remained largely flat at 14.5 percent.
The company said its international business continues to deteriorate due to unfavourable geopolitical situation and currency fluctuations in geographies such as the Middle East and Africa.
Growth in dairy business was also subdued primarily due to focus on driving products with high profitability and “reducing play” in the less profitable products, the company said in its release.
Our accelerated cost efficiency program and endeavour to leverage fixed costs have helped us improve our profitability on a sequential basis.Varun Berry, Managing Director, Britannia Industries
Britannia's shares touched a fresh record high after the results were announced. The stock rose as high as 7.6 percent to Rs 4,214.50, the highest value since at least January 1991.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
